These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6867010)

  • 1. Effect of AY-25,712 and other lipid-lowering agents on liver catalase and liver carnitine acetyltransferase in rats.
    Kallai-Sanfacon MA; Cayen MN; Dubuc J; Greselin E; Dvornik D
    Proc Soc Exp Biol Med; 1983 Jul; 173(3):367-71. PubMed ID: 6867010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The short- and long-term effects of bezafibrate in the rat.
    Fahimi HD; Reinicke A; Sujatta M; Yokota S; Ozel M; Hartig F; Stegmeier K
    Ann N Y Acad Sci; 1982; 386():111-35. PubMed ID: 6953842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the lipid-lowering activity of AY-25,712 in rats.
    Cayen MN; Kallai-Sanfacon MA; Dubuc J; Greselin E; Dvornik D
    Atherosclerosis; 1982 Dec; 45(3):267-79. PubMed ID: 6818976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ciprofibrate and 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme activities in rats. Relation between hepatic carnitine concentration and carnitine acetyltransferase activity.
    Bhuiyan AK; Bartlett K; Sherratt HS; Agius L
    Biochem J; 1988 Jul; 253(2):337-43. PubMed ID: 3178716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome-associated enzymes and serum lipids in tumour-bearing rats treated with peroxisome-proliferating agents.
    Moody DE; Reddy JK; Azarnoff DL
    Biochem Pharmacol; 1984 Aug; 33(16):2591-7. PubMed ID: 6431985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes.
    Moody DE; Reddy JK
    Am J Pathol; 1978 Feb; 90(2):435-46. PubMed ID: 623209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of AY-25,712 on fatty acid metabolism in rats.
    Cayen MN; Kallai-Sanfacon MA; Dubuc J; Greselin E; Dvornik D
    Atherosclerosis; 1982 Dec; 45(3):281-90. PubMed ID: 7159499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic peroxisome proliferation: induction by BR-931, a hypolipidemic analog of WY-14,643.
    Reddy JK; Azarnoff DL; Sirtori CR
    Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):4-14. PubMed ID: 708142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid metabolism in hepatocytes cultured with hypolipidaemic drugs. Role of carnitine.
    Gerondaes P; Alberti KG; Agius L
    Biochem J; 1988 Jul; 253(1):161-7. PubMed ID: 3048253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of ciprofibrate and clofibric acid as peroxisomal proliferators in primary cultures of rat hepatocytes.
    Feller DR; Singh Y; Shirhatti VR; Kocarek TA; Liu CT; Krishna G
    Hepatology; 1987; 7(3):508-16. PubMed ID: 3570161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic catalase is not essential for the hypolipidemic action of peroxisome proliferators.
    Reddy JK; Moody DE; Azarnoff DL; Rao MS
    Proc Soc Exp Biol Med; 1977 Apr; 154(4):483-7. PubMed ID: 859854
    [No Abstract]   [Full Text] [Related]  

  • 12. Di-(2-ethylhexyl)phthalate: an industrial plasticizer induces hypolipidemia and enhances hepatic catalase and carnitine acetyltransferase activities in rat and mice.
    Reddy JK; Moody DE; Azarnoff DL; Rao MS
    Life Sci; 1976 May; 18(9):941-5. PubMed ID: 1271963
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of some hypolipidemic drugs on biochemical values and on hepatic peroxisomal enzymes of normolipemic rat.
    Watanabe T; Manna H; Suga T
    J Pharmacobiodyn; 1981 Oct; 4(10):743-50. PubMed ID: 6798192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver.
    Lalwani ND; Reddy MK; Qureshi SA; Sirtori CR; Abiko Y; Reddy JK
    Hum Toxicol; 1983 Jan; 2(1):27-48. PubMed ID: 6840792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation of peroxisomes without simultaneous induction of the peroxisomal fatty acid beta-oxidation.
    Baumgart E; Völkl A; Pill J; Fahimi HD
    FEBS Lett; 1990 May; 264(1):5-9. PubMed ID: 2338145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of carnitine acetyltransferase by clofibrate in rat liver.
    Mittal B; Kurup CK
    Biochem J; 1981 Jan; 194(1):249-55. PubMed ID: 6796058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.
    Moody DE; Reddy JK
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):501-10. PubMed ID: 4445568
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypolipidemia and peroxisome proliferation induced by phenoxyacetic acid herbicides in rats.
    Vainio H; Linnainmaa K; Kähönen M; Nickels J; Hietanen E; Marniemi J; Peltonen P
    Biochem Pharmacol; 1983 Sep; 32(18):2775-9. PubMed ID: 6626247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of catalase synthesis and increase of carnitine acetyltransferase activity in the liver of intact female rats fed clofibrate.
    Reddy JK; Kumar NS
    J Biochem; 1979 Mar; 85(3):847-56. PubMed ID: 429267
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypolipidemic effect and enhancement of peroxisomal beta-oxidation in the liver of rats by sodium-(E)-3-(4-(3-pyridylmethyl)phenyl)-2-methyl propenoate (OKY-1581), a potent inhibitor of TxA2 synthetase.
    Watanabe T; Utsugi M; Mitsukawa M; Suga T; Fujitani H
    J Pharmacobiodyn; 1986 Dec; 9(12):1023-31. PubMed ID: 3572715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.